{"schema_version":"1","generated_at":"2026-11-04T08:15:44.726Z","data_as_of":null,"url":"https://www.findmykol.com/kol/elie-richa","json_url":"https://www.findmykol.com/kol/elie-richa/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"elie-richa","name":"Elie Richa","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"St. Joseph Hospital","institution_url":"https://www.findmykol.com/institution/st-joseph-hospital","city":"Eureka","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1518937838","openalex":"A5002369321"},"summary":"Elie Richa is an Oncology physician affiliated with St. Joseph Hospital. OpenAlex indexes 22 publications with 229 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":22,"cited_by_count":229,"h_index":9,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":15,"program_years":{"first":2021,"last":null},"rows_total":22,"shown":3,"withheld":19,"rows":[{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":143.57,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518937838"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":123.74,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518937838"},{"payer":"GlaxoSmithKline, LLC.","program_year":2025,"amount_usd":122.44,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518937838"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1518937838","source":"payments"},"prescribing":{"data_year":2024,"areas_total":10,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":32.4,"classes_total":9,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":9.5,"drugs":[{"name":"Letrozole","share_pct":45.6},{"name":"Anastrozole","share_pct":37.5},{"name":"Exemestane","share_pct":16.9}],"max_beneficiaries":null},{"class":"Thalidomide Analog","setting":"prescribed","share_pct":4.2,"drugs":[{"name":"Lenalidomide","share_pct":53.5},{"name":"Revlimid","share_pct":46.5}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":27.8,"classes_total":5,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":12.1,"drugs":[{"name":"Oxycodone Hcl","share_pct":43.8},{"name":"Methadone Hcl","share_pct":23.6},{"name":"Morphine Sulfate Er","share_pct":16.7},{"name":"Tramadol Hcl","share_pct":7.9},{"name":"Fentanyl","share_pct":7.9}],"max_beneficiaries":null},{"class":"Phenothiazine","setting":"prescribed","share_pct":5.9,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":76}]},{"area":"Metabolism & gastrointestinal","share_pct":16.6,"classes_total":6,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":7.6,"drugs":[{"name":"Ondansetron Odt","share_pct":59.1},{"name":"Ondansetron Hcl","share_pct":40.9}],"max_beneficiaries":45},{"class":"Corticosteroid","setting":"prescribed","share_pct":4.7,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":19}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":3.3,"facility_pct":96.7},"source":"medicare"},"publications":{"total":22,"shown":5,"withheld":17,"matched_by":"OpenAlex author record","recent":[{"title":"Bile Duct Hamartoma Mimicking Metastatic Cholangiocarcinoma","year":2016,"journal":"Journal of Gastrointestinal Cancer","source_url":"https://doi.org/10.1007/s12029-016-9802-z","status":"verified"},{"title":"Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions","year":2015,"journal":"Journal of Oncology Pharmacy Practice","source_url":"https://doi.org/10.1177/1078155215583523","status":"verified"},{"title":"Brief Communication: Eluate Testing Following Microscopically Positive Direct Antiglobulin Tests with Anti-IgG","year":2015,"status":"verified"},{"title":"Safety and Efficacy of FOLFOX Followed by Cetuximab for Metastatic Colorectal Cancer With Severe Liver Dysfunction","year":2014,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2014.0016","status":"verified"},{"title":"Automated red cell exchange: a simplified formula for how many red cell units to exchange and validity of haemoglobin S levels measured one to two hours later.","year":2014,"journal":"PubMed","source_url":"https://doi.org/10.2450/2013.0267-12","status":"verified"}],"source":"works"},"contact":{"address_1":"2700 DOLBEER ST","city":"Eureka","state":"CA","zip":"955014736","phone":"707-267-2060","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1518937838","source":"identity"},"similar":[{"name":"Timothy Harward","slug":"timothy-harward","institution":"St. Joseph Hospital","specialty":"Vascular Surgery","url":"https://www.findmykol.com/kol/timothy-harward","json_url":"https://www.findmykol.com/kol/timothy-harward/profile.json"},{"name":"Theodore Coutsoftides","slug":"theodore-coutsoftides","institution":"St. Joseph Hospital","specialty":"Colon & Rectal Surgery","url":"https://www.findmykol.com/kol/theodore-coutsoftides","json_url":"https://www.findmykol.com/kol/theodore-coutsoftides/profile.json"},{"name":"Robert Naraghi","slug":"robert-naraghi","institution":"St. Joseph Hospital","specialty":"Urology","url":"https://www.findmykol.com/kol/robert-naraghi","json_url":"https://www.findmykol.com/kol/robert-naraghi/profile.json"},{"name":"Oormila Kovilam","slug":"oormila-kovilam","institution":"St. Joseph Hospital","specialty":"Obstetrics & Gynecology","url":"https://www.findmykol.com/kol/oormila-kovilam","json_url":"https://www.findmykol.com/kol/oormila-kovilam/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":19,"publications":17}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-02-27","provider_certified":"2024-02-27","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}